成都先导(688222) - 2023 Q1 - 季度财报

First Quarter Report 2023 Important Notes The board guarantees the report's authenticity, and the financial statements are unaudited - The Board of Directors, Supervisory Committee, and senior management guarantee the authenticity, accuracy, and completeness of the quarterly report content[2] - The first quarter financial statements are unaudited[3] Key Financial Data This section outlines Q1 2023 financial data, non-recurring items, and explanations for key metric changes Key Accounting Data and Financial Indicators Q1 revenue slightly decreased, net profit was negative, but operating cash flow turned positive amid higher R&D spending Key Accounting Data and Financial Indicators | Item | Current Period Amount (CNY) | YoY Change (%) | | :--- | :--- | :--- | | Operating Revenue | 69,572,588.38 | -3.99 | | Net Profit Attributable to Shareholders | -9,393,596.88 | N/A | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) | -10,320,244.79 | N/A | | Net Cash Flow from Operating Activities | 19,779,297.51 | N/A | | Basic Earnings Per Share (CNY/Share) | -0.02 | N/A | | Diluted Earnings Per Share (CNY/Share) | -0.02 | N/A | | Total R&D Investment | 20,648,543.13 | 21.28 | | R&D Investment as a Percentage of Operating Revenue (%) | 29.68 | Increased by 6.19 percentage points | Key Balance Sheet Items | Item | End of Current Period (CNY) | End of Prior Year (CNY) | Change from Prior Year-End (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,656,729,729.98 | 1,668,990,981.13 | -0.73 | | Equity Attributable to Shareholders | 1,290,622,121.35 | 1,302,512,123.62 | -0.91 | Non-recurring Profit and Loss Items and Amounts Non-recurring P&L totaled CNY 926,647.91, primarily driven by government subsidies | Item | Current Period Amount (CNY) | Notes | | :--- | :--- | :--- | | Gain/Loss on Disposal of Non-current Assets | -3,141.88 | | | Government Grants Included in Current Profit or Loss | 1,097,679.95 | | | Other Non-operating Income and Expenses | 426.87 | | | Less: Income Tax Impact | 168,317.03 | | | Total | 926,647.91 | | Changes and Reasons for Key Accounting Data and Financial Indicators Increased R&D spending, positive operating cash flow from collections, and a wider net loss due to lower subsidies are noted - The ratio of R&D investment to operating revenue increased by 6.19 percentage points, mainly due to continuous upgrades of the DEL screening technology platform[5] - Net cash flow from operating activities was CNY 19.78 million, a significant turnaround from -CNY 5.80 million in the prior year period, driven by a substantial increase in sales collections[5] - Net loss attributable to shareholders was -CNY 9.39 million, compared to -CNY 7.09 million in the prior year period, primarily due to a decrease in government subsidies received[5] Shareholder Information This section details shareholder count, top ten shareholder holdings, and their relationships as of the report date Total Number of Common Shareholders and Top Ten Shareholders' Holdings The company had 11,921 common shareholders, with JIN LI (李进) being the largest shareholder at 20.43% - The total number of common shareholders at the end of the reporting period was 11,921[7] Top 10 Shareholders | Shareholder Name | Shareholder Type | Number of Shares Held (Shares) | Shareholding Ratio (%) | Number of Restricted Shares Held (Shares) | | :--- | :--- | :--- | :--- | :--- | | JIN LI(李进) | Foreign Individual | 81,876,948 | 20.43 | 81,876,948 | | Lhasa Economic and Technological Development Zone Huabo Medical Devices Co., Ltd. | Domestic Non-state-owned Corporation | 54,785,953 | 13.67 | 0 | | Chengdu Juzhi Kechuang Biotechnology Partnership (Limited Partnership) | Other | 38,651,163 | 9.65 | 38,651,163 | | Anji Dongfang Jiayu Enterprise Management Partnership (Limited Partnership) | Other | 33,665,721 | 8.40 | 0 | | Shenzhen Juntian Investment Enterprise (Limited Partnership) | Other | 20,132,314 | 5.02 | 0 | | Zhang Chi | Domestic Individual | 14,540,984 | 3.63 | 0 | | JUMBO KINDNESS LIMITED | Foreign Corporation | 13,815,543 | 3.45 | 0 | | Sichuan Development Securities Investment Fund Management Co., Ltd. - Chuanfa Select No. 3 Private Equity Fund | Other | 13,677,070 | 3.41 | 0 | | Hangzhou Dinghui New Trend Equity Investment Partnership (Limited Partnership) | Other | 12,243,377 | 3.06 | 0 | | Juntian Venture Capital Co., Ltd. | Domestic Non-state-owned Corporation | 11,931,448 | 2.98 | 0 | Top 10 Unrestricted Shareholders' Holdings Lhasa Economic and Technological Development Zone Huabo Medical Devices Co., Ltd. was the largest unrestricted shareholder | Shareholder Name | Number of Unrestricted Shares Held (Shares) | Share Type and Quantity (Shares) | | :--- | :--- | :--- | | Lhasa Economic and Technological Development Zone Huabo Medical Devices Co., Ltd. | 54,785,953 | RMB Ordinary Share 54,785,953 | | Anji Dongfang Jiayu Enterprise Management Partnership (Limited Partnership) | 33,665,721 | RMB Ordinary Share 33,665,721 | | Shenzhen Juntian Investment Enterprise (Limited Partnership) | 20,132,314 | RMB Ordinary Share 20,132,314 | | Zhang Chi | 14,540,984 | RMB Ordinary Share 14,540,984 | | JUMBO KINDNESS LIMITED | 13,815,543 | RMB Ordinary Share 13,815,543 | | Sichuan Development Securities Investment Fund Management Co., Ltd. - Chuanfa Select No. 3 Private Equity Fund | 13,677,070 | RMB Ordinary Share 13,677,070 | | Hangzhou Dinghui New Trend Equity Investment Partnership (Limited Partnership) | 12,243,377 | RMB Ordinary Share 12,243,377 | | Juntian Venture Capital Co., Ltd. | 11,931,448 | RMB Ordinary Share 11,931,448 | | Chongqing Boyi Xintian Equity Investment Fund Partnership (Limited Partnership) | 9,507,637 | RMB Ordinary Share 9,507,637 | | Long Star Growth Group Limited | 8,866,101 | RMB Ordinary Share 8,866,101 | Description of Related Parties or Concerted Actions The report discloses concerted action relationships among several key shareholders - JIN LI (李进), as the executive partner of Chengdu Juzhi Kechuang Biotechnology Partnership (Limited Partnership), is a party acting in concert with Juzhi Kechuang[9] - Shenzhen Juntian Investment Enterprise (Limited Partnership) and Juntian Venture Capital Co., Ltd. are parties acting in concert[9] - Hangzhou Dinghui New Trend Equity Investment Partnership (Limited Partnership) and Long Star Growth Group Limited are parties acting in concert[9] Other Matters No other significant operational matters requiring investor attention were disclosed for the reporting period - The company did not disclose other significant operational matters requiring investor attention during the reporting period[10] Quarterly Financial Statements This section presents the unaudited consolidated balance sheet, income statement, and cash flow statement for Q1 2023 Audit Opinion Type The quarterly financial statements have not been audited - The quarterly financial statements are unaudited[10] Consolidated Balance Sheet Total assets slightly decreased to CNY 1.66 billion, with shifts in current and non-current asset composition | Item | March 31, 2023 (CNY) | December 31, 2022 (CNY) | | :--- | :--- | :--- | | Cash and Cash Equivalents | 270,092,919.60 | 358,002,603.58 | | Trading Financial Assets | 622,425,916.67 | 542,049,777.78 | | Accounts Receivable | 73,097,113.83 | 96,904,322.40 | | Inventories | 29,281,806.09 | 25,269,024.97 | | Total Current Assets | 1,114,551,645.87 | 1,145,184,180.57 | | Intangible Assets | 69,294,219.06 | 51,874,893.82 | | Long-term Deferred Expenses | 49,137,297.51 | 46,328,167.04 | | Total Non-current Assets | 542,178,084.11 | 523,806,800.56 | | Total Assets | 1,656,729,729.98 | 1,668,990,981.13 | | Total Liabilities | 341,278,376.32 | 341,748,374.51 | | Total Equity Attributable to Parent Company | 1,290,622,121.35 | 1,302,512,123.62 | Consolidated Income Statement The company reported a net loss of CNY 9.39 million on revenue of CNY 69.57 million in Q1 2023 | Item | Q1 2023 (CNY) | Q1 2022 (CNY) | | :--- | :--- | :--- | | Total Operating Revenue | 69,572,588.38 | 72,465,855.95 | | Total Operating Costs | 87,582,724.31 | 91,164,576.82 | | R&D Expenses | 20,648,543.13 | 17,024,869.24 | | Operating Profit | -11,549,642.89 | -9,685,546.89 | | Total Profit | -11,552,357.90 | -8,392,138.60 | | Net Profit | -9,294,847.57 | -7,088,441.60 | | Net Profit Attributable to Parent Company Shareholders | -9,393,596.88 | -7,088,441.60 | | Basic Earnings Per Share (CNY/Share) | -0.02 | -0.02 | - R&D expenses increased by 21.28% YoY to CNY 20.65 million[15] - The net after-tax amount of other comprehensive income was -CNY 3.25 million, a narrowed loss compared to -CNY 12.91 million in the prior year period[16] Consolidated Cash Flow Statement Operating cash flow turned positive to CNY 19.78 million, while investing activities resulted in a significant cash outflow | Item | Q1 2023 (CNY) | Q1 2022 (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 19,779,297.51 | -5,800,253.79 | | Net Cash Flow from Investing Activities | -103,309,465.02 | 2,490,146.44 | | Net Cash Flow from Financing Activities | -2,903,899.50 | -15,544,681.65 | | Net Increase in Cash and Cash Equivalents | -89,305,620.50 | -19,955,814.13 | | Cash and Cash Equivalents at End of Period | 267,058,822.40 | 325,529,048.72 | - Cash received from sales of goods and rendering of services increased by 48.56% YoY to CNY 98.36 million[18] - Cash paid for the acquisition of fixed assets, intangible assets, and other long-term assets increased significantly from CNY 4.77 million to CNY 26.72 million[18]